Correction to : Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.
| Errataetall: |
ErratumFor: Invest New Drugs. 2013 Oct;31(5):1265-74. - PMID 23269537 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Investigational new drugs - 37(2019), 3 vom: 22. Juni, Seite 591 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ito, Tetsuhide [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 20.11.2019 published: Print ErratumFor: Invest New Drugs. 2013 Oct;31(5):1265-74. - PMID 23269537 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s10637-019-00757-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM295258616 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM295258616 | ||
| 003 | DE-627 | ||
| 005 | 20231225083253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10637-019-00757-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0984.xml |
| 035 | |a (DE-627)NLM295258616 | ||
| 035 | |a (NLM)30903344 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ito, Tetsuhide |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.11.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Invest New Drugs. 2013 Oct;31(5):1265-74. - PMID 23269537 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a In the original publication of this article, the license subtype should be CC BY and not CC BY-NC | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Okusaka, Takuji |e verfasserin |4 aut | |
| 700 | 1 | |a Nishida, Toshirou |e verfasserin |4 aut | |
| 700 | 1 | |a Yamao, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Igarashi, Hisato |e verfasserin |4 aut | |
| 700 | 1 | |a Morizane, Chigusa |e verfasserin |4 aut | |
| 700 | 1 | |a Kondo, Shunsuke |e verfasserin |4 aut | |
| 700 | 1 | |a Mizuno, Nobumasa |e verfasserin |4 aut | |
| 700 | 1 | |a Hara, Kazuo |e verfasserin |4 aut | |
| 700 | 1 | |a Sawaki, Akira |e verfasserin |4 aut | |
| 700 | 1 | |a Hashigaki, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kimura, Nobuyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Murakami, Mami |e verfasserin |4 aut | |
| 700 | 1 | |a Ohki, Emiko |e verfasserin |4 aut | |
| 700 | 1 | |a Chao, Richard C |e verfasserin |4 aut | |
| 700 | 1 | |a Imamura, Masayuki |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Investigational new drugs |d 1993 |g 37(2019), 3 vom: 22. Juni, Seite 591 |w (DE-627)NLM013000160 |x 1573-0646 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2019 |g number:3 |g day:22 |g month:06 |g pages:591 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10637-019-00757-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2019 |e 3 |b 22 |c 06 |h 591 | ||